Bridging the Gap: Strategic Preclinical Manufacturing for Viral Vector Success
The landscape of gene therapy is shifting. As the industry moves from speculative R&D toward a robust clinical pipeline, the...
The landscape of gene therapy is shifting. As the industry moves from speculative R&D toward a robust clinical pipeline, the...
For years, the medical community has grappled with the devastating aftermath of severe COVID-19. Beyond the initial viral assault, many...
In an audacious display of ingenuity and perhaps a touch of madness, a team of independent inventors operating under the...
Duchenne muscular dystrophy (DMD), a devastating genetic condition characterized by progressive muscle degeneration, has long remained a "holy grail" for...